Your browser doesn't support javascript.
loading
Valsartan, Losartan and Irbesartan use in the USA, UK, Canada and Denmark after the nitrosamine recalls: a descriptive cohort study.
Eworuke, Efe; Shinde, Mayura; Hou, Laura; Paterson, Michael J; Jensen, Peter Bjødstrup; Maro, Judith C; Rai, Ashish; Scarnecchia, Daniel; Pennap, Dinci; Woronow, Daniel; Ghosh, Rebecca E; Welburn, Stephen; Pottegard, Anton; Platt, Robert W; Lee, Hana; Bradley, Marie C.
Affiliation
  • Eworuke E; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA efeeworuke@gmail.com.
  • Shinde M; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA.
  • Hou L; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA.
  • Paterson MJ; Canadian Network for Observational Drug Effect Studies (CNODES), Montréal, Quebec, Canada.
  • Jensen PB; University of Southern Denmark, Odense, Denmark.
  • Maro JC; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA.
  • Rai A; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA.
  • Scarnecchia D; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA.
  • Pennap D; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
  • Woronow D; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
  • Ghosh RE; Clinical Practice Research Datalink, Medicines and Healthcare Products Regulatory, London, UK.
  • Welburn S; Clinical Practice Research Datalink, Medicines and Healthcare Products Regulatory, London, UK.
  • Pottegard A; Hospital Pharmacy, Odense Universitetshospital, Odense, Denmark.
  • Platt RW; Department of Public Health, Clinical Pharmacology and Pharmacy, University of Southern Denmark, Odense, Denmark.
  • Lee H; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA.
  • Bradley MC; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
BMJ Open ; 13(4): e070985, 2023 04 17.
Article in En | MEDLINE | ID: mdl-37068898
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Losartan / Hypertension Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Country/Region as subject: America do norte / Europa Language: En Journal: BMJ Open Year: 2023 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Losartan / Hypertension Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Country/Region as subject: America do norte / Europa Language: En Journal: BMJ Open Year: 2023 Type: Article Affiliation country: United States